These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22670880)

  • 41. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.
    Nalini A; Thennarasu K; Gourie-Devi M; Shenoy S; Kulshreshtha D
    J Neurol Sci; 2008 Sep; 272(1-2):60-70. PubMed ID: 18550082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with survival in the National Registry of Veterans with ALS.
    Pastula DM; Coffman CJ; Allen KD; Oddone EZ; Kasarskis EJ; Lindquist JH; Morgenlander JC; Norman BB; Rozear MP; Sams LA; Sabet A; Bedlack RS
    Amyotroph Lateral Scler; 2009; 10(5-6):332-8. PubMed ID: 19922120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical, demographic and prognostic features of sporadic amyotrophic lateral sclerosis in Northern Turkey.
    Aksoy D; Cevik B; Solmaz V; Kurt SG
    Int J Neurosci; 2014 Jan; 124(1):68-73. PubMed ID: 23837674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics and Prognosis of Oldest Old Subjects with Amyotrophic Lateral Sclerosis.
    Dandaba M; Couratier P; Labrunie A; Nicol M; Hamidou B; Raymondeau M; Logroscino G; Preux PM; Marin B;
    Neuroepidemiology; 2017; 49(1-2):64-73. PubMed ID: 28873374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictability of disease progression in amyotrophic lateral sclerosis.
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Muscle Nerve; 2006 Dec; 34(6):702-8. PubMed ID: 16967489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience.
    Gordon PH; Salachas F; Lacomblez L; Le Forestier N; Pradat PF; Bruneteau G; Elbaz A; Meininger V
    Neurodegener Dis; 2013; 12(2):81-90. PubMed ID: 22922503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
    Eur J Neurol; 2006 Jul; 13(7):789-92. PubMed ID: 16834713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period.
    Testa D; Lovati R; Ferrarini M; Salmoiraghi F; Filippini G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):208-12. PubMed ID: 15799548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies.
    Ragonese P; Filippini G; Salemi G; Beghi E; Citterio A; D'Alessandro R; Marini C; Monsurrò MR; Aiello I; Morgante L; Tempestini A; Fratti C; Ragno M; Pugliatti M; Epifanio A; Testa D; Savettieri G
    Neuroepidemiology; 2004; 23(1-2):73-7. PubMed ID: 14739571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register.
    Scialò C; Novi G; Bandettini di Poggio M; Canosa A; Sormani MP; Mandich P; Origone P; Truffelli R; Mancardi GL; Caponnetto C
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):535-542. PubMed ID: 27399231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients.
    Martínez HR; Molina-López JF; Cantú-Martínez L; González-Garza MT; Moreno-Cuevas JE; Couret-Alcaraz P; Treviño SA; Webb-Vargas Y; Caro E; Gil-Valadez A; Santos-Guzmán J; Hernandez-Torre M
    Amyotroph Lateral Scler; 2011 May; 12(3):199-205. PubMed ID: 21344998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural history of young-adult amyotrophic lateral sclerosis.
    Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
    Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease progression and survival in ALS: first multi-state model approach.
    Gil J; Preux PM; Alioum A; Ketzoian C; Desport JC; Druet-Cabanac M; Couratier P
    Amyotroph Lateral Scler; 2007 Aug; 8(4):224-9. PubMed ID: 17653920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors predicting survival in ALS: a multicenter Italian study.
    Calvo A; Moglia C; Lunetta C; Marinou K; Ticozzi N; Ferrante GD; Scialo C; Sorarù G; Trojsi F; Conte A; Falzone YM; Tortelli R; Russo M; Chiò A; Sansone VA; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Monsurrò MR; Sabatelli M; Riva N; Logroscino G; Messina S; Fini N; Mandrioli J
    J Neurol; 2017 Jan; 264(1):54-63. PubMed ID: 27778156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A predictive model for amyotrophic lateral sclerosis (ALS) diagnosis.
    Gupta PK; Prabhakar S; Sharma S; Anand A
    J Neurol Sci; 2012 Jan; 312(1-2):68-72. PubMed ID: 21907354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of ALS in Italy: a 10-year prospective population-based study.
    Chiò A; Mora G; Calvo A; Mazzini L; Bottacchi E; Mutani R;
    Neurology; 2009 Feb; 72(8):725-31. PubMed ID: 19237701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rate of disease progression: a prognostic biomarker in ALS.
    Labra J; Menon P; Byth K; Morrison S; Vucic S
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The electromyographic diagnosis of amyotrophic lateral sclerosis: does the evidence support the El Escorial criteria?
    Makki AA; Benatar M
    Muscle Nerve; 2007 May; 35(5):614-9. PubMed ID: 17294439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.